Publicaciones en colaboración con investigadores/as de Karolinska University Hospital (21)

2024

  1. OMERACT systemic lupus erythematosus domain survey

    Seminars in Arthritis and Rheumatism, Vol. 68

2023

  1. Evaluating the Construct of Damage in Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 75, Núm. 5, pp. 998-1006

  2. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    The Lancet Rheumatology

2021

  1. Impact of glucocorticoids on the incidence of lupus-related major organ damage: A systematic literature review and meta-regression analysis of longitudinal observational studies

    Lupus Science and Medicine, Vol. 8, Núm. 1

2020

  1. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Arthritis and Rheumatology, Vol. 72, Núm. 1, pp. 67-77

  2. Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study

    Annals of Intensive Care, Vol. 10, Núm. 1

  3. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

    Journal of Autoimmunity, Vol. 106

2019

  1. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires

    Clinical Pharmacology and Therapeutics, Vol. 106, Núm. 2, pp. 374-382

  2. EULAR recommendations for the management of antiphospholipid syndrome in adults

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 10, pp. 1296-1304

  3. Osteopontin and disease activity in patients with recent-onset systemic Lupus Erythematosus: Results from the SLICC Inception Cohort

    Journal of Rheumatology, Vol. 46, Núm. 5, pp. 492-500

2018

  1. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires

    Clinical Pharmacology and Therapeutics, Vol. 103, Núm. 6, pp. 1074-1082

  2. Correction to: Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit (Intensive Care Medicine, (2018), 44, 7, (1027-1038), 10.1007/s00134-018-5196-7)

    Intensive Care Medicine

  3. Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients

    Arthritis Care and Research, Vol. 70, Núm. 1, pp. 98-103

  4. Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit

    Intensive Care Medicine, Vol. 44, Núm. 7, pp. 1027-1038

2017

  1. Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study

    Arthritis Research and Therapy, Vol. 19, Núm. 1

  2. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years)

    Intensive Care Medicine, Vol. 43, Núm. 12, pp. 1820-1828

2016

  1. Off-label use of rituximab for systemic lupus erythematosus in Europe

    Lupus Science and Medicine, Vol. 3, Núm. 1

2015

  1. Anti-C1q antibodies in systemic lupus erythematosus

    Lupus, Vol. 24, Núm. 1, pp. 42-49

  2. State of the art: Reproduction and pregnancy in rheumatic diseases

    Autoimmunity Reviews, Vol. 14, Núm. 5, pp. 376-386

2012

  1. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 64, Núm. 8, pp. 2677-2686